Bharat Biotech's Covaxin to cost Rs 600 for state govts, Rs 1,200 for pvt hospitals
At these rates, Covaxin will be twice as costly as Covishield, which will be sold to state governments at Rs 400 per dose and to private hospitals at Rs 600 per dose in Phase 3 of vacccination drive

- Apr 24, 2021,
- Updated Apr 24, 2021 11:21 PM IST
Bharat Biotech has announced that it will sell its COVID-19 vaccine, Covaxin, to state government at Rs 600 for a dose and to private hospitals at Rs 1,200 per dose. The company also said that it will export the vaccine at $15-20 (Rs 1124-1499) per dose.
"Recovering costs is essential in the journey of innovation towards other vaccines such as intranasal COVID-19, chikungunya, zika, cholera and others. Our core mission for the last 25 years has been to provide affordable yet world class healthcare solutions for the globe," said Bharat Biotech Chairman and Managing Director Krishna Ella.
Bharat Biotech has announced prices under directives from the central government regarding its next phase in COVID-19 vaccination programme that is scheduled to kick off on May 1. Centre had asked vaccine manufacturers to supply 50 per cent of their capacities to state governments and private hospitals at a pre-determined rate. This phase aims to inoculate every citizen above the age of 18.
(Edited by Vivek Punj)
Bharat Biotech has announced that it will sell its COVID-19 vaccine, Covaxin, to state government at Rs 600 for a dose and to private hospitals at Rs 1,200 per dose. The company also said that it will export the vaccine at $15-20 (Rs 1124-1499) per dose.
"Recovering costs is essential in the journey of innovation towards other vaccines such as intranasal COVID-19, chikungunya, zika, cholera and others. Our core mission for the last 25 years has been to provide affordable yet world class healthcare solutions for the globe," said Bharat Biotech Chairman and Managing Director Krishna Ella.
Bharat Biotech has announced prices under directives from the central government regarding its next phase in COVID-19 vaccination programme that is scheduled to kick off on May 1. Centre had asked vaccine manufacturers to supply 50 per cent of their capacities to state governments and private hospitals at a pre-determined rate. This phase aims to inoculate every citizen above the age of 18.
(Edited by Vivek Punj)